Literature DB >> 22787407

The importance of a satisfactory biopsy for the diagnosis of lung cancer in the era of personalized treatment.

L M Ofiara1, A Navasakulpong, N Ezer, A V Gonzalez.   

Abstract

Advances in molecular biology are improving the understanding of lung cancer and changing the approach to treatment. A satisfactory biopsy that allows for histologic characterization and mutation analysis is becoming increasingly important. Most patients with lung cancer are diagnosed at an advanced stage, and diagnosis is often based on a small biopsy or cytology specimen. Here, we review the techniques available for making a diagnosis of lung cancer, including bronchoscopy, ultrasound-guided bronchoscopy, mediastinoscopy, transthoracic needle aspiration, thoracentesis, and medical thoracoscopy. We also discuss the indications, complications, and tissue yields of those techniques, especially as they pertain to testing for molecular markers.

Entities:  

Keywords:  EGFR; Lung cancer; bronchoscopy; diagnosis; endobronchial ultrasonography; molecular markers; thoracoscopy; transthoracic needle aspiration

Year:  2012        PMID: 22787407      PMCID: PMC3377750          DOI: 10.3747/co.19.1062

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  51 in total

1.  Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial.

Authors:  Ralf Eberhardt; Devanand Anantham; Armin Ernst; David Feller-Kopman; Felix Herth
Journal:  Am J Respir Crit Care Med       Date:  2007-03-22       Impact factor: 21.405

2.  Nonsurgical staging of the mediastinum: EBUS and EUS.

Authors:  Felix J F Herth
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

3.  Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma.

Authors:  J Popovich; P A Kvale; M S Eichenhorn; J R Radke; J M Ohorodnik; G Fine
Journal:  Am Rev Respir Dis       Date:  1982-05

4.  Thoracoscopy in malignant pleural effusions.

Authors:  C Boutin; J R Viallat; P Cargnino; P Farisse
Journal:  Am Rev Respir Dis       Date:  1981-11

5.  Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.

Authors:  Anthony Lemaire; Ivana Nikolic; Thomas Petersen; Jack C Haney; Eric M Toloza; David H Harpole; Thomas A D'Amico; William R Burfeind
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

6.  Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules.

Authors:  W A Baaklini; M A Reinoso; A B Gorin; A Sharafkaneh; P Manian
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

7.  Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.

Authors:  U B Prakash; H M Reiman
Journal:  Mayo Clin Proc       Date:  1985-03       Impact factor: 7.616

8.  Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy.

Authors:  Armin Ernst; Devanand Anantham; Ralf Eberhardt; Mark Krasnik; Felix J F Herth
Journal:  J Thorac Oncol       Date:  2008-06       Impact factor: 15.609

9.  The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.

Authors:  D Sears; S I Hajdu
Journal:  Acta Cytol       Date:  1987 Mar-Apr       Impact factor: 2.319

10.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Authors:  Giorgio Vittorio Scagliotti; Purvish Parikh; Joachim von Pawel; Bonne Biesma; Johan Vansteenkiste; Christian Manegold; Piotr Serwatowski; Ulrich Gatzemeier; Raghunadharao Digumarti; Mauro Zukin; Jin S Lee; Anders Mellemgaard; Keunchil Park; Shehkar Patil; Janusz Rolski; Tuncay Goksel; Filippo de Marinis; Lorinda Simms; Katherine P Sugarman; David Gandara
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

View more
  17 in total

1.  Ready or not? Lung cancer diagnosis in 2015.

Authors:  K Jao; C Labbe; N B Leighl
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

Review 2.  The state of the art for artificial intelligence in lung digital pathology.

Authors:  Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Pathol       Date:  2022-06-20       Impact factor: 9.883

3.  Investigation of tissue cellularity at the tip of the core biopsy needle with optical coherence tomography.

Authors:  Nicusor Iftimia; Jesung Park; Gopi Maguluri; Savitri Krishnamurthy; Amanda McWatters; Sharjeel H Sabir
Journal:  Biomed Opt Express       Date:  2018-01-18       Impact factor: 3.732

4.  Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Authors:  Benjamin P Levy; Marc D Chioda; Dana Herndon; John W Longshore; Mohamed Mohamed; Sai-Hong Ignatius Ou; Craig Reynolds; Jaspal Singh; Ignacio I Wistuba; Paul A Bunn; Fred R Hirsch
Journal:  Oncologist       Date:  2015-09-01

5.  Contrast-enhanced ultrasound for needle biopsy of central lung cancer with atelectasis.

Authors:  Zhikai Lei; Jun Lou; Lingyun Bao; Zhuying Lv
Journal:  J Med Ultrason (2001)       Date:  2017-12-14       Impact factor: 1.314

6.  Patterns of diagnostic procedures for lung cancer pathology in the Middle East and North Africa.

Authors:  Abdul Rahman Jazieh; Adda Bounedjar; Foad Al Dayel; Shamayel Fahem; Arafat Tfayli; Kakil Rasul; Hassan Jaafar; Mohammad Jaloudi; Turki Al Fayea; Hatim Q Almaghrabi; Hanaa Bamefleh; Khaled AlKattan; Blaha Larbaoui; Taha Filalli; Mufid Al Mistiri; Hamed Alhusaini
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

7.  Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting.

Authors:  Pasquale Pisapia; Francesco Pepe; Riccardo Smeraglio; Maria Russo; Danilo Rocco; Roberta Sgariglia; Mariantonia Nacchio; Caterina De Luca; Elena Vigliar; Claudio Bellevicine; Giancarlo Troncone; Umberto Malapelle
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.

Authors:  Melissa Paoloni; Craig Webb; Christina Mazcko; David Cherba; William Hendricks; Susan Lana; E J Ehrhart; Brad Charles; Heather Fehling; Leena Kumar; David Vail; Michael Henson; Michael Childress; Barbara Kitchell; Christopher Kingsley; Seungchan Kim; Mark Neff; Barbara Davis; Chand Khanna; Jeffrey Trent
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

9.  Clinical Implications of "Atypia" on Biopsy: Possible Precursor to Lung Cancer?

Authors:  Denise Albano; Lee Ann Santore; Thomas Bilfinger; Melissa Feraca; Samantha Novotny; Barbara Nemesure
Journal:  Curr Oncol       Date:  2021-07-06       Impact factor: 3.677

10.  Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology.

Authors:  Mei He; Jennifer Crow; Marc Roth; Yong Zeng; Andrew K Godwin
Journal:  Lab Chip       Date:  2014-10-07       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.